ArticleThe New England journal of medicine2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Viral N Shah et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleThe New England journal of medicine2021
Viral N Shah et al.PubMed ↗Publisher ↗
No numbers read from the abstract.